liposomal glutathione parkinson& 39 Liposomes: An emerging carrier for targeting Alzheimer's and Parkinson's diseases: Heliyon Lipid Nanoparticles: Promising Treatment Approach

Description

& Sharma, C

Downstream synthetic route of [ 70-18-8 ] [ 70-18-8 ] Synthesis Path-Downstream 1~80 References: [1]Inami, Keiko

Exp Biol Med (Maywood) (2019) 244:63045

The management of patients include patient-reported outcomes for long-term follow-up care and for early detection of possible adverse events and the use of digital technologies, such as telemedicine - videoconferences for patients follow-up and reinfection risk elimination, digital therapeutics approach, especially for non-pharmaceutical interventions (e.g., breathing exercises), electronic control of body parameters such as temperature, oxygen saturation, blood pressure, that can be measured with wearable devices and the data can be analyzed with artificial intelligence (256, 257)